Impact of diverting ileostomy on functional outcome and quality of life after restorative proctocolectomy and ileal pouch anal anastomosis
Colorectal Disease · 2024-11 · 26 (11) · 1931-1940
DOI: 10.1111/codi.17196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Disease, online erschienen am 03.10.2024. Verfasst von Gregory Martin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive and General Surgery, AP-HP, Hôpital Saint Antoine, Sorbonne University, Paris, France. Hauptthemen laut MEDLINE: Proctocolectomy, Restorative, Quality of Life, Ileostomy, Colonic Pouches. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
Diverting ileostomy (DS) after restorative proctocolectomy (RPC) can be omitted in selected patients. Its omission could improve functional outcomes and quality of life (QoL), as has been demonstrated in patients after proctectomy. The aim of this study was to report the impact of diverting ileostomy on functional outcomes and QoL after ileal pouch‐anal anastomosis (IPAA).
Methods
This was a retrospective study including all patients operated (2015–2020) for RPC with IPAA. Functional outcome was evaluated by validated scores (LARS, Wexner, Öresland, pouch functional score [PFS] and the ileoanal pouch syndrome severity [IPSS] score). Global health‐related QoL was evaluated with the SF‐36. We also analysed demographic characteristics, morbidity, correlation between functional outcomes and QoL.
Results
Among 179 eligible patients, 150 responded (84%): S− (no stoma = 78; 52%) and S+ (had stoma = 72; 48%). Overall morbidity and anastomotic leak rates were 46% and 9.3%, respectively without difference between the groups. Medians for the functional scores were comparable between the S− and S+ group, respectively: 18 [12.5–31] versus 18 [11–31], p = 0.48 for LARS; 9 [7–11] versus 9 [7–12], p = 0.23 for Wexner's score; 6 [3–13] versus 8 [5–11], p = 0.22 for Öresland's score, 6 [3–13] versus 6.8 [4–12], p = 0.174 for PFS score, and 40 [35–45] versus 46 [42–51], p = 0.045 for IPSS score. The SF‐36 summary score was comparable between the two groups without any difference in eight specific health dimensions. After propensity score matching, results were still comparable between the two groups for all scores. Linear regression found a significant correlation between all QoL domains and all functional scores ( p < 0.001).
Conclusion
DS for IPAA does not alter either functional outcomes or QoL and can be omitted in selected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Digestive and General Surgery, AP-HP, Hôpital Saint Antoine, Sorbonne University, Paris, France.
- Centre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.
ORCID-Profile: Maxime Collard, Lauren O'Connell, Alexandre Challine, Jeremie H Lefèvre
Zitieren
APA
Martin, G., Voron, T., Collard, M., O'Connell, L., Challine, A., Chafai, N., Lefèvre, J. H., & Parc, Y. (2024). Impact of diverting ileostomy on functional outcome and quality of life after restorative proctocolectomy and ileal pouch anal anastomosis. Colorectal Disease, 26(11), 1931-1940. https://doi.org/10.1111/codi.17196
Vancouver
Martin G, Voron T, Collard M, O'Connell L, Challine A, Chafai N, et al. Impact of diverting ileostomy on functional outcome and quality of life after restorative proctocolectomy and ileal pouch anal anastomosis. Colorectal Disease. 2024;26(11):1931-1940. doi:10.1111/codi.17196
BibTeX
@article{Martin2024,
author = {Martin, Gregory and Voron, Thibault and Collard, Maxime and O'Connell, Lauren and Challine, Alexandre and Chafai, Najim and Lefèvre, Jeremie H and Parc, Yann},
title = {Impact of diverting ileostomy on functional outcome and quality of life after restorative proctocolectomy and ileal pouch anal anastomosis},
journal = {Colorectal Disease},
year = {2024},
volume = {26},
number = {11},
pages = {1931--1940},
doi = {10.1111/codi.17196}
}
EUVIMED